Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Briakinumab [USAN:INN]
RN: 339308-60-0
UNII: 978I8M0P8X

Note

  • Blocks the binding of IL-12 and IL-23 to their shared IL-12 receptor betal.

Molecular Formulas

  • C6376-H9874-N1722-O1992-S44
  • Unspecified
 

Classification Code

  • Treatment of Autoimmune Disorders
* denotes mobile formatted website

Links to Resources

Names and Synonyms

Name of Substance

  • ABT-874 antibody, human
  • Briakinumab [USAN:INN]

Synonyms

  • A-796874.0
  • ABT 874
  • ABT-874
  • Briakinumab
  • BSF 415977
  • J 695
  • J-695
  • J695
  • LU 415977
  • UNII-978I8M0P8X
  • WAY 165772
  • WAY-165772

Systematic Names

  • Briakinumab
  • Immunoglobulin G1, anti-(human interleukin-12 subunit beta (IL-12 subunit p40, CLMF p40 or NKSF2)); human monoclonal gamma1 heavy chain (218-216')-disulfide with human monoclonal gamma light chain, dimer (224-224'':227-227'')-bisdisulfide
  • J 695

Registry Numbers

CAS Registry Number

  • 339308-60-0

FDA UNII

  • 978I8M0P8X

System Generated Number

  • 0339308600